Battling aging by preserving telomeres could backfire, fueling cancer

If an anti-aging regimen that involves telomeres – part of the human chromosome – sounds too good to be true, it probably is, says Jens Schmidt, a postdoctoral fellow in the Cech Lab at CU Boulder’s BioFrontiers Institute.

Read the rest of this entry

Tucatinib (ONT-380) progressing in pivotal trial against HER2+ breast cancer

27 percent of heavily pretreated patients saw clinical benefit from the drug, with at least “stable disease” at 24 or more weeks after the start of treatment.

Read the rest of this entry

CSU veterinarians help bring groundbreaking cancer drug to market

Through its clinical trials for animal patients, University of Colorado Cancer Center member institution Colorado…

Read the rest of this entry

Little survival benefit and higher costs in advanced non-small cell lung cancer associated with new drugs

CU Cancer Center study shows that a decade that saw the development of new therapies for non-small cell lung cancer resulted in little survival benefit for patients with advanced-stage disease.

Read the rest of this entry

Women’s Event Supports Research

Cancer assassins. That’s how Julie Clark, creator of Baby Einstein and speaker at this year’s…

Read the rest of this entry

Strong is the new healthy

By: Lisa Marshall In the second-floor weight room at the Anschutz Health and Wellness Center,…

Read the rest of this entry

A conversation with Nobel Laureate, Thomas R. Cech, PhD

In 1982, a young CU chemist named Tom Cech was the first to show that…

Read the rest of this entry

No plans but life itself

Jerry Williams has no big plans for his future. And he likes it that way….

Read the rest of this entry

A mix of East and West

Manali Kamdar’s journey to specializing in the treat­ment of lymphomas with blood and marrow trans­plantation…

Read the rest of this entry

Cancer and the Microbiome

Does your gut hold the key to your cancer? Octopus Springs, eight miles north of…

Read the rest of this entry